V
Viracta Therapeutics Inc
F:RYI
Viracta Therapeutics Inc
F:RYI
Price:
0.0895
EUR
Market Closed
Market Cap:
€3.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
V
|
Viracta Therapeutics Inc
F:RYI
|
US |
|
D
|
Deal Pro Capital Corp
XTSX:DPCC.P
|
CA |
|
G
|
Greenbriar Capital Corp
OTC:GEBRF
|
CA |
|
G
|
Gakkyusha Co Ltd
TSE:9769
|
JP |
|
M
|
Multipolar Tbk PT
XBER:MLQ2
|
ID |
|
CANEX Metals Inc
XTSX:CANX
|
CA |
|
C
|
China Dili Group
OTC:RNHEF
|
CN |
|
K
|
Kross Ltd
NSE:KROSS
|
IN |
|
I
|
Iren SpA
SWB:TZ8
|
IT |
|
Castillo Copper Ltd
ASX:CCZ
|
AU |
|
C
|
Chung Hwa Food Industrial Co Ltd
TPEX:4205
|
TW |
|
J
|
Jiangsu Phoenix Property Investment Co Ltd
SSE:600716
|
CN |
|
T
|
Terrace Energy Corp
OTC:TCRRF
|
CA |
|
C
|
Clip Corp
TSE:4705
|
JP |
|
B
|
Blue Prism Group PLC
F:B11
|
UK |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of RYI.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
RYI
Multiples-Based Value
Base Case
Not Available
